• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
Nairametrics
Home Companies Company News

Emzor and 2 other pharmaceutical companies shut down over codeine

Emmanuel Abara Benson by Emmanuel Abara Benson
May 8, 2018
in Company News
Codeine-in-Nigeria

Codeine abuse has become a prevalent crisis in Nigeria

Share on FacebookShare on TwitterShare on Linkedin

Three companies- Emzor Pharmaceuticals Limited, Peace Standard Pharmaceutical Limited, and Bioraj Pharmaceutical Limited were last week shut down by NAFDAC following an investigation which incriminated them in the codeine syrup crisis.

NAFDAC’s Director General,  Mojisola Adeyeye, in a statement, noted that the move became imperative after the uncovering of evidence (despite inconclusive investigation) by a Task Force she constituted. The Task Force comprised of NAFDAC Directors for Registration and Regulatory Affairs, Narcotics & Controlled Substances, and Drug Evaluation & Research. Also on the committee are the Executive Secretary of the Pharmaceutical Manufacturers Group of Manufacturers Association of Nigeria, and representatives of Emzor Pharmaceutical Industries, May & Baker, and Fidson Healthcare.

The inspection took place between May 2nd and 3rd, first at the manufacturing plants of Peace Standard Pharmaceutical Limited, and Bioraj Pharmaceutical Limited in Ilorin, and then at Emzor’s facility in Lagos. All three companies were hitherto licensed to produce codeine-containing cough syrup.

MoreStories

Meet 13 female Executive Directors powering Nigeria’s NGX 30 companies

Meet 13 female Executive Directors powering Nigeria’s NGX 30 companies

February 12, 2026
BUA Foods Plc announces executive leadership appointment  

Isyaku Abdulsamad Rabiu: Meet Georgetown graduate now BUA head of procurement

February 12, 2026

 Due to insufficient evidence gathered and apparent resistance to provide needed documents during our inspection on May 2, 2018 at the respective companies in Ilorin and Lagos, respectively, it has become necessary to shut down all product lines of the three companies – Peace Standard Pharmaceutical Limited. Plots 3 & 8, Adewole Industrial Estate, Lubcon Avenue, Ilorin, Kwara State; Bioraj Pharmaceutical Limited. No 405 Kaima Road, Ilorin, Kwara State and Emzor Pharmaceuticals Ind. Ltd., Ajao Estate, Lagos. This is to allow for a full and comprehensive investigation. The three companies therefore remain closed.-NAFDAC

In the meantime, the three pharmaceutical companies will remain shut, depending on the level of cooperation the investigation committee receives during a subsequent and thorough inspection.

It took a BBC documentary to throw open the controversy

Late last month, the BBC aired Nigeria’s deadly codeine cough syrup epidemic, an investigative documentary which shed light on the rising cases of Nigeria’s youths’ addiction to codeine. The documentary asked vital questions about the manufacturers’ of the cough syrup, thereby prompting the government to take action by banning the products.

It is unsurprising that the above-named companies have been shut down.

Would this affect the companies?

Without a doubt, Emzor Pharmaceutical Industries Limited and the two other companies have a major crisis to grapple with which has the potential to destabilize their business. Asides the fact that the shut down would potentially affect their daily business operations and by extension their revenue/profit, they would also have to struggle with integrity issues as customers resort to alternatives for the sake of quality and safety.


Add Nairametrics on Google News
Follow us for Breaking News and Market Intelligence.
Tags: Bioraj PharmaceuticalCodeine syrup crisisEmzor PharmaceuticalsNAFDACNews ReviewPeace Standard Pharmaceutical
Emmanuel Abara Benson

Emmanuel Abara Benson

Emmanuel Abara Benson is an experienced business reporter and editor. He currently edits articles at Nairametrics. Reach him via email on Emmanuel.abara@nairametrics.com and follow him on Twitter @Mr_Abara for his personal opinions.

Next Post
Austin Avuru

Seplat unveils plans for the rest of 2018

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

rabafast

nairametrics








DUNS

Follow us on social media:

  • HOME
  • ABOUT NAIRAMETRICS
  • CONTACT US
  • DISCLAIMER
  • ADs DISCLAIMER
  • COPYRIGHT INFRINGEMENT

© 2026 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Login
  • Sign Up

© 2026 Nairametrics